Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 124.60
+1.10 (0.89%)
Oct 1, 2026, 2:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 19.51 million as of October 2, 2026. Its market cap has decreased by -43.39% in one year.
Market Cap
19.51M
Enterprise Value
25.01M
Revenue
4.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
124.60
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 19.51M, a decrease of -82.75%. That is a compound annual growth rate of -8.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 19.51M | -25.52% |
| Dec 31, 2025 | 26.20M | -44.67% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 77.30M |
| BioLineRx | 38.83M |
| Clal Biotechnology Industries | 37.96M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 26.91M |
| XTL Biopharmaceuticals | 25.16M |
| Can-Fite BioPharma | 20.06M |